Point-of-care medical diagnostic sensors for early coronary heart disease detection
Enterprise Solutions supported partnership development between Zimmer & Peacock and the University of Plymouth's Dr Shakil Awan to create proof-of-concept sensors for the detection of protein biomarkers of Coronary Heart Disease (CHD). The aim of this technology is to lead to point-of-care diagnostic capabilities for the early detection of CHD.
The purpose of this project was to start building a profitable product line for the early diagnosis of CVD, to improve care and outcomes for patients whilst reducing the impact on the UK economy. The funding allowed graphene sensor development to include the detection of higher concentration levels of Troponin I, to cover a range found in healthy and diseased patient samples.